<DOC>
	<DOCNO>NCT01308190</DOCNO>
	<brief_summary>The standard treatment rectal adenocarcinoma total mesorectal excision ( TME ) . The technique involve low anterior rectal colo-anal resection , often associate protective stoma abdominal-perineal resection permanent colostomy . Transanal endoscopic microsurgery ( TEM ) allow access tumor 20 cm anal margin , minimal postoperative morbidity mortality . Recent study T1 rectal adenocarcinoma consider TEM technique choice . However treatment T2 rectal cancer remain controversial . Chemotherapy radiotherapy ( CT/RT ) achieve concomitant reduction local recurrence increase survival . Hypothesis : Patients rectal adenocarcinoma less 10 cm anal margin 4 cm size , stag endorectal ultrasound MRI T2 superficial T3 N0-M0-N0-M0 , underwent surgery preoperative local chemoradiotherapy ( TEM ) , achieve effective result term local recurrence similar radical surgery ( TME ) . OBJECTIVES : Primary : To compare result local recurrence 2 year patient treat preoperative chemoradiotherapy TEM patient treat conventional radical surgery ( TME ) . Secondary : To analyse 3-year survival result patient treated CT/RT . Methodology : Multicenter clinical trial calculate sample 173 patient .</brief_summary>
	<brief_title>Preoperative Chemoradiotherapy Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision T2-T3s N0 , M0 Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>1 . Rectal adenocarcinoma locate 10 cm less inferior anal verge measure use rigid rectoscope time EUS . 2 . Preoperative stag EUS pelvic MRI T2 T3 superficial , N0 . In case disparity , high staging consider definitive diagnosis . 3 . Tumours equal less 4 cm diameter maximum measure use colonoscopy , EUS MRI . We use high score score . 4 . ASA score III less . 5 . Absence distance metastasis show abdominal CT. 1 . Preoperative stag EUS pelvic MRI T1 , deep T3 , T4 N1 . 2 . Presence distance metastasis . 3 . Synchrony colorectal adenocarcinoma . 4 . Undifferentiated rectal adenocarcinoma presence poor prognosis factor preoperative biopsy . 5 . Patients intolerance preoperative chemotherapy radiotherapy . 6 . Refusal sign inform consent enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Preoperative chemoradiotherapy</keyword>
	<keyword>Transanal endoscopic microsurgery</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>T2-T3s-N0</keyword>
</DOC>